Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
6 hedge funds and large institutions have $1.45M invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
2.1% less ownership
Funds ownership: 12.41% → 10.31% (-2.1%)
42% less capital invested
Capital invested by funds: $2.52M → $1.45M (-$1.07M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.84K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$56 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$242K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$95.6K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$61.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$47.6K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OMC
1
Old Mission Capital
Chicago,
Illinois
| $717K | -$61.1K | -5,458 | -8% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $412K | -$95.6K | -8,539 | -18% |
|
|
3
Goldman Sachs
New York
| $196K | -$242K | -21,649 | -54% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $120K | -$47.6K | -4,252 | -28% |
|
|
5
UBS Group
Zurich,
Switzerland
| $4K | +$3.84K | +343 | New |
|
|
6
Simplex Trading
Chicago,
Illinois
| – | -$2K | -200 | Closed |
|
|
7
Fidelity Investments
Boston,
Massachusetts
| – | +$56 | +5 | New |
|
PILL Hedge Fund Activity: Q2 2022 in Review
6 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q2 2022, worth a combined $1.45M — down 42% from $2.52M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PILL positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 4 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $3.84K. The largest seller was Goldman Sachs, cutting an estimated $242K.
- 6 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q2 2022, up from 5 in Q1 2022.
- Funds reported $1.45M of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q2 2022, down 42% quarter-over-quarter.
- 2 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q2 2022 and 1 closed out, a net change of +1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q2 2022 was UBS Group, an estimated $3.84K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q2 2022 was Goldman Sachs, an estimated $242K sold.
Based on aggregated 13F filings for Q2 2022.